<DOC>
	<DOCNO>NCT01977196</DOCNO>
	<brief_summary>The objective study know safety DTP/Hepatitis B Hib/PRP-T vaccine immediate reaction within first 30 minute injection .</brief_summary>
	<brief_title>The Safety Immunogenicity DTP/Hepatitis B 10ug Hib Vaccine ( Bio Farma )</brief_title>
	<detailed_description>This trial open-label study , randomization , placebo control group . Total 30 healthy infant ( age 6-11 week ) follow trial . The safety assess within 24 hour , 48 hour , 72 hour , 28 day injection .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infant 611 week age Infant born 3742 week pregnancy Infant weight 2.5 kg birth Father , mother legally acceptable representative properly inform study sign informed consent form Parents commit comply indication investigator schedule trial Child concomitantly enroll schedule enroll another trial Evolving moderate severe illness , especially infectious disease fever ( axillary temperature &gt; =37.5 Celsius Day 0 ) Known history allergy component vaccine component ( e.g.formaldehyde ) History uncontrolled coagulopathy blood disorder contraindicate intramuscular injection Known history congenital acquire immunodeficiency ( include HIV infection ) Child receive previous 4 week treatment likely alter immune response ( intravenous immunoglobulin , blood derive product long term corticotherapy ( &gt; 2 minggu ) Other vaccination within 7 day prior inclusion exception BCG poliomyelitis Any abnormality chronic disease accord investigator might interfere assessment trial objective Infant know history diphteria , tetanus , pertussis , Hib , Hepatitis B infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>11 Weeks</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>DTB/HB/Hib vaccine</keyword>
	<keyword>Infants</keyword>
	<keyword>Phase I</keyword>
</DOC>